Abstract:Key PointsNew blood vessel morphogenesis by angiogenic sprouting requires the highly coordinated and dynamic control of endothelial cell (EC) behaviour. Recent studies shed new light on the complex molecular mechanisms controlling EC behaviour in sprouting vessels, providing important insights into key biological processes, such as branching morphogenesis, tubulogenesis and mechanotransduction.Angiogenic branching involves the hierarchical sprouting of leading endothelial 'tip cells' (TCs) and trailing 'stalk cells' (SCs). Signalling via vascular endothelial growth factor receptor 2 (VEGFR2) and VEGFR3 promotes TC behaviour, whereas expression of the decoy receptor, VEGFR1, limits TC formation.Activation of Notch signalling in SCs negatively regulates VEGFR function to repress TC behaviour and maintain the hierarchical organization of sprouting TCs and SCs. Consequently, the cell-type-specific transcriptional control of Notch ligand expression or the post-translational control of Notch activity act as key control points that determine TC and SC fate.Vascular tubulogenesis is an essential aspect of angiogenic sprouting that generates a blood vessel lumen capable of carrying blood flow. Emerging evidence indicates that vascular lumen formation is a multistep process that is initiated by the acquisition of EC apicobasal polarity and is regulated by cell–matrix interactions, as well as partitioning defective 3 (PAR3) and VEGFR signalling.Increasing evidence shows that multiple signalling pathways have common roles in the guidance of both migrating axonal growth cones and ECs. In particular, signalling mediated by the neuronal guidance cues uncoordinated 5 homologue B (UNC5B), Roundabout homologue 4 (ROBO4), plexin D1, neuropilins, ephrin B2 and ephrin receptor B4 (EPHB4) has key roles in vascular development.Post-transcriptional control of blood vessel formation by microRNAs is involved in the fine-tuning of pro-angiogenic signalling during development, disease and in response to mechanical cues, such as blood flow. Furthermore, recent studies identify important post-translational mechanisms that control VEGFR membrane trafficking and signalling during angiogenesis in vivo.

Glycolytic regulation of cell rearrangement in angiogenesis

The role of glycolysis and mitochondrial respiration in the formation and functioning of endothelial tip cells during angiogenesis

Therapeutic Efficacy of ECs Foxp1 Targeting Hif1α-Hk2 Glycolysis Signal to Restrict Angiogenesis

Therapeutic Efficacy of ECs Foxp1 Targeting Hif1α-Hk2 Α-Hk2 Glycolysis Signal to Restrict Angiogenesis

Endothelial PFKFB3 Plays a Critical Role in Angiogenesis.

Abstract 719: PFKFB3 Mediated Glycolysis in Vascular Smooth Muscle Cells is Essential for Arterial Neointima Formation

Metabolic reprogramming and interventions in angiogenesis

Integrative modeling of sprout formation in angiogenesis: coupling the VEGFA-Notch signaling in a dynamic stalk-tip cell selection

Endothelial Drp1 Couples VEGF-induced Redox Signaling with Glycolysis Through Cysteine Oxidation to Drive Angiogenesis

PFKFB3: A Potential Key to Ocular Angiogenesis

A simulation of parental and glycolytic tumor phenotype competition predicts observed responses to pH changes and increased glycolysis after anti-VEGF therapy

Endothelial sprouting, proliferation, or senescence: tipping the balance from physiology to pathology

Computational modelling of angiogenesis: The importance of cell rearrangements during vascular growth

Glycolysis links reciprocal activation of myeloid cells and endothelial cells in the retinal angiogenic niche

Molecular control of endothelial cell behaviour during blood vessel morphogenesis

Basic and Therapeutic Aspects of Angiogenesis Updated

Angiogenic Factors produced by Hypoxic Cells are a leading driver of Anastomoses in Sprouting Angiogenesis---a computational study

Targeting PFKFB3 in the Endothelium for Cancer Therapy.

Roles of KLF4 and AMPK in the inhibition of glycolysis by pulsatile shear stress in endothelial cells

Glycosylation as new pharmacological strategies for diseases associated with excessive angiogenesis

Targeting Vegf Pathway To Normalize The Vasculature: An Emerging Insight In Cancer Therapy